The European Respiratory Journal

Lung scarring linked to flare-ups in chronic lung disease

Higher scarring was linked to flare-ups in two patient cohorts, with hazard ratios—measures of relative risk over time—of 1.39 and 3.35.

Our read

Biomarkers
Studied:
Cohort study of patients with COPD, median 4.98 years
What changed:
Future flare-up risk was higher with more lung scarring (hazard ratio 1.39 and 3.35 across two cohorts)
The catch:
The abstract omits the reference groups and scarring increments behind the hazard ratios

Editor of record: Boris Djordjevic · AgingResearch.News

Follow @agingbrief

This observational study included 346 lung cancer screening participants and two prospective cohorts of patients with chronic obstructive pulmonary disease: 234 at Kyoto University and 166 at Kyoto-Himeji. The disease restricts airflow. Researchers used a mathematical method to measure fibrosis, or scarring, as a share of lung volume on computed tomography scans.

In both disease cohorts, more scarring at the start was linked to future flare-ups, independently of emphysema—damage to lung air sacs—and airway wall thickness. The hazard ratios were 1.39 and 3.35, respectively. Higher baseline scarring was also linked to mortality at Kyoto University, with a similar trend at Kyoto-Himeji. In the Kyoto University cohort, increases in scarring over a median 4.98 years were linked to more frequent flare-ups. Patients with greater increases subsequently had higher mortality.

Why it matters

Chronic obstructive pulmonary disease is a concern for health in later life. The authors suggest that measuring lung scarring on scans could help assess its likely course.

Caveats

These observational associations do not show that scarring caused flare-ups or death. The abstract does not specify the scarring increments or reference groups behind the hazard ratios.

Comments

Be the first to comment.